Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory
MedTech
Medtronic claims long-sought FDA approval in renal denervation
Medtronic claimed the FDA's second green light in renal denervation this month, as it competes with Recor for a potential multibillion-dollar market.
Conor Hale
Nov 20, 2023 10:21am
FDA clears first OTC home antigen test for COVID-19. No, really
Nov 10, 2023 3:58pm
Recor claims 1st FDA renal denervation approval for hypertension
Nov 8, 2023 10:07am
Medtronic claims FDA nod for extravascular defibrillator implant
Oct 23, 2023 11:17am
EU orders Illumina to split from Grail as penance for $8B deal
Oct 12, 2023 11:14am
FDA to form advisory committee for digital health and AI
Oct 11, 2023 2:27pm